alexa Synthesis And Evaluation Of Some Hydrazone Derivatives Of Pyrazole-4-carboxaldehydes As Antileishmanial Agents
ISSN: 2155-9597

Journal of Bacteriology & Parasitology
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Share This Page

Additional Info

Loading Please wait..

International Congress on Bacteriology & Infectious Diseases
November 20-22, 2013 DoubleTree by Hilton Baltimore-BWI Airport, MD, USA

Halefom Gebreselasse Berhe
Posters: J Bacteriol Parasitol
DOI: 10.4172/2155-9597.S1.003
As part of the work in search for novel antileishmanial agents, some hydrazone derivatives of pyrazole-4-carboxaldehydes were synthesized. The chemical structures of the synthesized compounds were verified by IR, 1HNMR and elemental microanalyses. The in vitro antileishmanial activity test was done against Leishmania aethiopica isolate CL 048/11 promastigotes using alamar blue reduction assay. The search for antileishmanial agents in this work resulted in compounds 3a, 3b, 4 and 6, among which compound 4; N,N-dimethylaminomethylene-4-[(3-(4-methylphenyl)-4-(phenylhydrazonomethylene))-1H-pyrazol-1-yl] benzenesulfonamide (IC50=0.0175) was found to be about 180 times more active than the miltefosine (IC50=3.1300) and 2.7 times more active than amphotericin B deoxycholate (IC50=0.0470), the standard reference drugs. This high activity could probably be due to the interaction of its hydrazone and sulfonamide moieties with electrophilic groups on the backbone of the relevant receptor´┐Żs active site. The results of acute toxicity test indicated that compounds 3a, 3b, 3d, 4, and 5 proved to be non-toxic and well tolerated by the experimental animals up to a dose level of 300 mg/kg orally, while compound 6 was tolerated up to 200 mg/kg. On the other hand, all the test compounds were well tolerated up to 140 mg/kg parenteraly. Therefore, compound 4 would represent a fruitful matrix of new class of antileishmanial agents that would deserve further investigations and derivatizations.

Halefom Gebreselasse has completed his B. Pharm degree at the age of 23 years from Jimma University and M.Sc. study from Addis Ababa University, School of Pharmacy by 2011. Currently, he is working in Mekelle University as a Lecturer and researcher. He has got a letter of appreciation from the Ethiopian pharmaceutical association for the contribution he made during the attempt of the association to play role in the improvement of the community health service. Moreover, his role in changing the countrywide pharmaceutical curriculum from product oriented to clinical oriented one was magnificent.

image PDF   |   image HTML

Relevant Topics

Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version